During the past decade, Nizhniy Novgorod City Hospital 33 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nizhniy Novgorod City Hospital 33" are "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Nizhniy Novgorod City Hospital 33" in a lesser frequency.

Most popular intervention types in "Nizhniy Novgorod City Hospital 33" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Interferon beta-1a" (1 trials), "Ozanimod" (1 trials), "Placebo to interferon beta-1a" (1 trials), "Placebo to ozanimod" (1 trials) and "RPC1063" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nizhniy Novgorod City Hospital 33" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nizhniy Novgorod City Hospital 33". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nizhniy Novgorod City Hospital 33, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nizhniy Novgorod City Hospital 33, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".